Christopher G. Przybycin

3.8k total citations
56 papers, 1.5k citations indexed

About

Christopher G. Przybycin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Christopher G. Przybycin has authored 56 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 27 papers in Molecular Biology and 15 papers in Surgery. Recurrent topics in Christopher G. Przybycin's work include Renal cell carcinoma treatment (25 papers), Renal and related cancers (20 papers) and Urologic and reproductive health conditions (11 papers). Christopher G. Przybycin is often cited by papers focused on Renal cell carcinoma treatment (25 papers), Renal and related cancers (20 papers) and Urologic and reproductive health conditions (11 papers). Christopher G. Przybycin collaborates with scholars based in United States, Canada and Spain. Christopher G. Przybycin's co-authors include Jesse K. McKenney, Ie‐Ming Shih, Brigitte M. Ronnett, Russell Vang, Robert J. Kurman, Cristina Magi‐Galluzzi, Jordan Reynolds, Kiril Trpkov, Jane Nguyen and Ankur R. Sangoi and has published in prestigious journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and Journal of Virology.

In The Last Decade

Christopher G. Przybycin

52 papers receiving 1.5k citations

Peers

Countries citing papers authored by Christopher G. Przybycin

Since Specialization

Citations

This map shows the geographic impact of Christopher G. Przybycin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher G. Przybycin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher G. Przybycin more than expected).

Fields of papers citing papers by Christopher G. Przybycin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher G. Przybycin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher G. Przybycin. The network helps show where Christopher G. Przybycin may publish in the future.

Co-authorship network of co-authors of Christopher G. Przybycin

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher G. Przybycin. A scholar is included among the top collaborators of Christopher G. Przybycin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher G. Przybycin. Christopher G. Przybycin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Primary Ewing Sarcoma of the Kidney 2025 ·The American Journal of Surgical Pathology ·João Lobo, Huiying He, (unknown), (unknown), Thomas S. Winokur, Shi Wei, Shuko Harada, Jesse K. McKenney, Jonathan Myles, Jane Nguyen, Christopher G. Przybycin, Sean R. Williamson, Cristina Magi‐Galluzzi, Reza Alaghehbandan	0
2	Atypical Intraductal Proliferation in Prostate Needle Core Biopsy 2025 ·The American Journal of Surgical Pathology ·(unknown), Jesse K. McKenney, Reza Alaghehbandan, Xuefeng Liu, Roni M. Cox, Jonathan Myles, Christopher G. Przybycin, Sean R. Williamson, Christopher Weight, Zeyad Schwen, Jane Nguyen	4
3	Fibroadenoma of the vulva with pseudoangiomatous stromal hyperplasia: A common neoplasm in uncommon site 2024 ·Journal of Cutaneous Pathology ·(unknown), Anurag Sharma, Christopher G. Przybycin, Melissa Piliang	1
4	Papillary Renal Cell Carcinoma: Evolving Classification by Combined Morphologic and Molecular Means 2024 ·Advances in Anatomic Pathology ·Christopher G. Przybycin	2
5	Impact of pathologic re-review on grade, clinical stage, and risk stratification for patients with nonmuscle invasive bladder cancer 2024 ·Urologic Oncology Seminars and Original Investigations ·Rebecca A. Campbell, Andrew Wood, (unknown), David S. Shin, (unknown), Samuel Haywood, Mohamed Eltemamy, Christopher Weight, Georges‐Pascal Haber, Byron Lee, Jonathan Myles, Jesse K. McKenney, Jane Nguyen, Sean R. Williamson, Christopher G. Przybycin, Reza Alaghehbandan, Nima Almassi	3
6	Surgical Management and Oncologic Outcomes of Renal Cell Carcinoma and Inferior Vena Caval Thrombi With Aggressive Histologic Variants 2023 ·Urology ·(unknown), Glenn T. Werneburg, Molly Dewitt‐Foy, Scott D. Lundy, Mohamed Eltemamy, Prithvi Murthy, Christopher G. Przybycin, Steven C. Campbell, Christopher Weight, Venkatesh Krishnamurthi	2
7	Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma 2021 ·European Urology ·Òscar Reig, Akhilesh Mishra, Alana Christie, Tiffani McKenzie, Oreoluwa Onabolu, Nirmish Singla, Elizabeth R. Plimack, Cristina Suárez, Moshe Chaim Ornstein, R. Katherine Alpaugh, Roy Elias, I. Alex Bowman, Renée M. McKay, Christopher G. Przybycin, Payal Kapur, James Brugarolas, Brian I. Rini	9
8	MDM2 amplification in malignant Brenner tumors may play a role in progression to malignancy and aid in separation from urothelial and other ovarian carcinomas 2021 ·Human Pathology ·(unknown), (unknown), (unknown), Caroline Astbury, Christopher G. Przybycin, Amy Joehlin‐Price	3
9	Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updates 2021 ·Asian journal of urology ·Reza Alaghehbandan, Christopher G. Przybycin, Virginie Verkarre, Rohit Mehra	21
10	Deep androgen receptor suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposure 2020 ·Annals of Oncology ·Mohammad Alyamani, (unknown), (unknown), Sarah Taylor, (unknown), Michael Berk, Christopher G. Przybycin, Edwin M. Posadas, Ravi A. Madan, James L. Gulley, Brian I. Rini, J. Garcia, Eric A. Klein, Nima Sharifi	17
11	Immunohistochemical staining patterns of Ki-67 and p53 in florid reactive urothelial atypia and urothelial carcinoma in situ demonstrate significant overlap 2020 ·Human Pathology ·Jane Nguyen, Christopher G. Przybycin, Jesse K. McKenney, Cristina Magi‐Galluzzi	17
12	Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary 2020 ·Modern Pathology ·Arnaud Da Cruz Paula, Edaise M. da Silva, Sheila Segura, Fresia Pareja, Rui Bi, Pier Selenica, Sarah H. Kim, Lorenzo Ferrando, Mahsa Vahdatinia, Robert A. Soslow, August Vidal, Sónia Gatius, Christopher G. Przybycin, Nadeem R. Abu‐Rustum, Xavier Matías‐Guiu, Brian P. Rubin, Jorge S. Reis‐Filho, Deborah F. DeLair, Britta Weigelt	39
13	A Novel Dual Immunostain to Characterize Sloughed Cells in Testicular Biopsies for Infertility 2019 ·The American Journal of Surgical Pathology ·Hari Prasad Dhakal, Jennifer Coleman, Christopher G. Przybycin	3
14	Evaluation of T cell infiltration in matched biopsy and nephrectomy samples in renal cell carcinoma 2018 ·Medicine ·Haris Zahoor, Paul G. Pavicic, Christopher G. Przybycin, Jennifer S. Ko, Lisa Stephens, Tomas Radivoyevitch, Xuefei Jia, C. Marcela Díaz‐Montero, James H. Finke, Patricia Rayman, Timothy D. Gilligan, Petros Grivas, Moshe Chaim Ornstein, Jorge A. García, Brian I. Rini	5
15	Eosinophilic, Solid, and Cystic Renal Cell Carcinoma 2015 ·The American Journal of Surgical Pathology ·Kiril Trpkov, Ondřej Hes, Michael Bonert, José I. López, Stephen M. Bonsib, Gabriella Nesi, Éva Compérat, Mathilde Sibony, Daniel M. Berney, Petr Martínek, Stela Bulimbašić, Saul Suster, Ankur R. Sangoi, Aslı Yilmaz, Julian P. T. Higgins, Ming Zhou, Anthony J. Gill, Christopher G. Przybycin, Cristina Magi‐Galluzzi, Jesse K. McKenney	132
16	Tuberous Sclerosis–associated Renal Cell Carcinoma 2014 ·The American Journal of Surgical Pathology ·Juan Guo, Maria Tretiakova, Megan L. Troxell, Adeboye O. Osunkoya, Oluwole Fadare, Ankur R. Sangoi, Steven S. Shen, Antonio López-Beltrán, Rohit Mehra, Amer Heider, Julian P. T. Higgins, Lara R. Harik, Xavier Leroy, Anthony J. Gill, Kiril Trpkov, Steven C. Campbell, Christopher G. Przybycin, Cristina Magi‐Galluzzi, Jesse K. McKenney	185
17	Rhabdoid Differentiation Is Associated With Aggressive Behavior in Renal Cell Carcinoma 2014 ·The American Journal of Surgical Pathology ·Christopher G. Przybycin, Jesse K. McKenney, Jordan Reynolds, Steven C. Campbell, Ming Zhou, Matthew Karafa, Cristina Magi‐Galluzzi	48
18	Hereditary Syndromes With Associated Renal Neoplasia 2013 ·Advances in Anatomic Pathology ·Christopher G. Przybycin, Cristina Magi‐Galluzzi, Jesse K. McKenney	28
19	Chromophobe Renal Cell Carcinoma 2011 ·The American Journal of Surgical Pathology ·Christopher G. Przybycin, (unknown), Farbod Darvishian, Anuradha Gopalan, Hikmat Al‐Ahmadie, Samson W. Fine, Ying‐Bei Chen, Melanie Bernstein, Paul Russo, Victor E. Reuter, Satish K. Tickoo	83
20	Regression of metastatic seminoma in a patient referred for carcinoma of unknown primary origin 2010 ·Nature Reviews Urology ·John E. Musser, Christopher G. Przybycin, Paul Russo	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact